The CDK4/6 Inhibitor Drugs Market has witnessed significant growth in recent years, driven by advances in cancer treatment. Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors have emerged as a critical class of targeted therapies in oncology, particularly for treating hormone receptor-positive breast cancer. This article provides an in-depth analysis of the Global CDK 4/6 Inhibitor Drugs...